Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
4.430
+0.060 (1.37%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of $472.55 million as of September 4, 2026. Its market cap has increased by 868.33% in one year.
Market Cap
472.55M
Enterprise Value
254.82M
1-Year Change
868.33%
Ranking
Category
Stock Price
$4.43
ChartMarket Cap Chart
Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $472.55M, an increase of 734.89%. That is a compound annual growth rate of 21.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 472.55M | 33.41% |
| Dec 31, 2025 | 354.20M | 2,156.05% |
| Dec 31, 2024 | 15.70M | -87.40% |
| Dec 29, 2023 | 124.60M | 18.67% |
| Dec 30, 2022 | 105.00M | -73.42% |
| Dec 31, 2021 | 395.00M | -24.17% |
| Dec 31, 2020 | 520.90M | 30.00% |
| Dec 31, 2019 | 400.70M | 1,125.38% |
| Dec 31, 2018 | 32.70M | 247.87% |
| Dec 29, 2017 | 9.40M | -28.24% |
| Dec 30, 2016 | 13.10M | -54.67% |
| Dec 31, 2015 | 28.90M | -48.94% |
| Sep 30, 2015 | 56.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Entera Bio | 505.57M |
| Puma Biotechnology | 500.20M |
| Prothena Corporation | 497.20M |
| Eupraxia Pharmaceuticals | 490.48M |
| Rezolute | 476.37M |
| Arcturus Therapeutics Holdings | 475.80M |
| Ginkgo Bioworks Holdings | 473.40M |
| Editas Medicine | 473.03M |